Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000995:Antitubercular Agents / Q000008:administration & dosage*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004977:Ethambutol / Q000008:administration & dosage*; D005000:Ethionamide / Q000008:administration & dosage; D007538:Isoniazid / Q000008:administration & dosage; D008168:Lung / Q000382:microbiology; D051379:Mice; D012293:Rifampin / Q000008:administration & dosage*; D013154:Spleen / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin